Clinical Trial Update: A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating ASP1941 in combination with pioglitazone in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED